Rakesh Premkumar1, Anthony R J Phillips2, Maxim S Petrov2, John A Windsor3. 1. Surgical Center for Outcomes Research and Evaluation, Department of Surgery & Applied Surgery and Metabolism Laboratory, School of Biological Sciences, University of Auckland, Auckland, New Zealand. Electronic address: r.premkumar@auckland.ac.nz. 2. Surgical Center for Outcomes Research and Evaluation, Department of Surgery & Applied Surgery and Metabolism Laboratory, School of Biological Sciences, University of Auckland, Auckland, New Zealand. 3. Surgical Center for Outcomes Research and Evaluation, Department of Surgery & Applied Surgery and Metabolism Laboratory, School of Biological Sciences, University of Auckland, Auckland, New Zealand. Electronic address: j.windsor@auckland.ac.nz.
Abstract
BACKGROUND: With the rising prevalence of obesity, its impact on the severity and outcome of acute pancreatitis remains an important consideration when managing obese patients with acute pancreatitis. OBJECTIVE: To determine the clinical relevance of obesity in acute pancreatitis. METHODS: A series of clinically relevant questions were framed which formed the basis of our literature search using PubMed and EMBASE databases. These related to acute pancreatitis severity, systemic inflammatory response, mortality, local and systemic complications. The search was restricted to human studies. Studies were classified according to the Oxford Centre for Evidence Based Medicine levels of evidence 1 for prognostic studies. Obesity was defined according to the guidelines of the World Health Organization. In keeping with studies included the binary classification (mild and severe) of acute pancreatitis was used. RESULTS: Obesity is associated with an amplified systemic inflammatory response in acute pancreatitis and is a prognostic factor for mortality, local, systemic complications and severity in acute pancreatitis. Obesity was not found to be an independent prognostic factor for mortality and organ failure in patients with acute pancreatitis. It was evident that further studies are required to determine whether incorporating obesity into existing scoring systems improves severity prediction. Emerging evidence suggests that an obesity paradox is present in patients with acute pancreatitis. CONCLUSION: This review demonstrates that obesity has a clinically relevant impact on the course and outcome of acute pancreatitis.
BACKGROUND: With the rising prevalence of obesity, its impact on the severity and outcome of acute pancreatitis remains an important consideration when managing obesepatients with acute pancreatitis. OBJECTIVE: To determine the clinical relevance of obesity in acute pancreatitis. METHODS: A series of clinically relevant questions were framed which formed the basis of our literature search using PubMed and EMBASE databases. These related to acute pancreatitis severity, systemic inflammatory response, mortality, local and systemic complications. The search was restricted to human studies. Studies were classified according to the Oxford Centre for Evidence Based Medicine levels of evidence 1 for prognostic studies. Obesity was defined according to the guidelines of the World Health Organization. In keeping with studies included the binary classification (mild and severe) of acute pancreatitis was used. RESULTS:Obesity is associated with an amplified systemic inflammatory response in acute pancreatitis and is a prognostic factor for mortality, local, systemic complications and severity in acute pancreatitis. Obesity was not found to be an independent prognostic factor for mortality and organ failure in patients with acute pancreatitis. It was evident that further studies are required to determine whether incorporating obesity into existing scoring systems improves severity prediction. Emerging evidence suggests that an obesity paradox is present in patients with acute pancreatitis. CONCLUSION: This review demonstrates that obesity has a clinically relevant impact on the course and outcome of acute pancreatitis.
Authors: Katherine F Sweeny; Tom K Lin; Jaimie D Nathan; Lee A Denson; Sohail Z Husain; Lindsey Hornung; Tyler Thompson; Maisam Abu-El-Haija Journal: J Pediatr Gastroenterol Nutr Date: 2019-01 Impact factor: 2.839
Authors: Somashekar G Krishna; Alice Hinton; Veeral Oza; Phil A Hart; Eric Swei; Samer El-Dika; Peter P Stanich; Hisham Hussan; Cheng Zhang; Darwin L Conwell Journal: Am J Gastroenterol Date: 2015-10-20 Impact factor: 10.864
Authors: Aliye Uc; M Bridget Zimmerman; Michael Wilschanski; Steven L Werlin; David Troendle; Uzma Shah; Sarah Jane Schwarzenberg; Sue Rhee; John F Pohl; Emily R Perito; Joseph J Palermo; Chee Y Ooi; Quin Liu; Tom K Lin; Veronique D Morinville; Brian A McFerron; Sohail Z Husain; Ryan Himes; Melvin B Heyman; Tanja Gonska; Matthew J Giefer; Cheryl E Gariepy; Steven D Freedman; Douglas S Fishman; Melena D Bellin; Bradley Barth; Maisam Abu-El-Haija; Mark E Lowe Journal: Pancreas Date: 2018-09 Impact factor: 3.327
Authors: Hanna Sternby; Mariella Mahle; Nicolas Linder; Laureen Erichson-Kirst; Robert C Verdonk; Alexandra Dimova; Povilas Ignatavicius; Lucas Ilzarbe; Peeter Koiva; Anne Penttilä; Sara Regnér; Thomas L Bollen; Richard Brill; Franz Stangl; Walter A Wohlgemuth; Vijay Singh; Harald Busse; Patrick Michl; Sebastian Beer; Jonas Rosendahl Journal: United European Gastroenterol J Date: 2019-10-09 Impact factor: 4.623
Authors: Savio George Barreto; Aida Habtezion; Anna Gukovskaya; Aurelia Lugea; Christie Jeon; Dhiraj Yadav; Peter Hegyi; Viktória Venglovecz; Robert Sutton; Stephen J Pandol Journal: Gut Date: 2020-09-24 Impact factor: 23.059